BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12642008)

  • 1. The effect of aldosterone on glucose metabolism.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 2003 Apr; 5(2):106-9. PubMed ID: 12642008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Okazaki-Hada M; Moriya A; Nagao M; Oikawa S; Fukuda I; Sugihara H
    J Diabetes Investig; 2020 Nov; 11(6):1511-1519. PubMed ID: 32470155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism and metabolic syndrome.
    Fallo F; Pilon C; Urbanet R
    Horm Metab Res; 2012 Mar; 44(3):208-14. PubMed ID: 22116746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
    Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
    Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
    Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
    Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of insulin sensitivity and secretion in primary aldosteronism.
    Watanabe D; Yatabe M; Ichihara A
    Clin Exp Hypertens; 2016; 38(7):613-617. PubMed ID: 27669369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
    Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose Metabolism in Primary Aldosteronism.
    Remde H; Hanslik G; Rayes N; Quinkler M
    Horm Metab Res; 2015 Dec; 47(13):987-93. PubMed ID: 26667801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of patients for surgery for primary aldosteronism.
    Plouin PF; Rossignol P; Amar L
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):522-5. PubMed ID: 18307754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of hypokalemia on glucose metabolism in primary hyperaldosteronism].
    Zhang J; Zeng ZP; Zhou YR; Tong AL; Lu L; Song AL; Yan ZL; Chen S; Liang W; Li YX; Qin SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):745-9. PubMed ID: 17260459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?
    Widimský J; Strauch B; Sindelka G; Skrha J
    Physiol Res; 2001; 50(6):603-7. PubMed ID: 11829322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary diabetes mellitus due to primary aldosteronism.
    Moustaki M; Paschou SA; Vakali EC; Vryonidou A
    Endocrine; 2023 Jan; 79(1):17-30. PubMed ID: 36001240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased insulin sensitivity in patients with aldosterone producing adenoma.
    Ishimori M; Takeda N; Okumura S; Murai T; Inouye H; Yasuda K
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):433-8. PubMed ID: 7955454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links between aldosterone excess and metabolic complications: A comprehensive review.
    Bothou C; Beuschlein F; Spyroglou A
    Diabetes Metab; 2020 Feb; 46(1):1-7. PubMed ID: 30825519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia.
    Li N; Wang M; Wang H; Zhang D; Wang X; Zu F; Chang G; Zhou K
    Clin Exp Hypertens; 2013; 35(3):175-82. PubMed ID: 22913631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible association between primary aldosteronism and a lower beta-cell function.
    Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
    J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is primary aldosteronism underdiagnosed in clinical practice?
    Fiquet-Kempf B; Launay-Mignot P; Bobrie G; Plouin PF
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1083-6. PubMed ID: 11903321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.